Log In
Print
BCIQ
Print
Print this Print this
 

dipraglurant-IR (ADX48621)

  Manage Alerts
Collapse Summary General Information
Company Addex Therapeutics Ltd.
DescriptionImmediate-release formulation of dipraglurant, a negative allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5)
Molecular Target Metabotropic glutamate receptor subtype 5 (mGluR5) (GRM5)
Mechanism of ActionMetabotropic glutamate receptor subtype 5 (mGluR5) modulator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today